|
|
Volumn 102, Issue 3 I, 1998, Pages 648-651
|
|
Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
IMMUNOGLOBULIN;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
HIGH RISK POPULATION;
HUMAN;
LUNG DYSPLASIA;
NOTE;
PREMATURITY;
PRIORITY JOURNAL;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
INFANT;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
|
|
EID: 0031682215
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: 10.1542/peds.102.3.648 Document Type: Note |
|
Times cited : (44)
|
|
References (15)
|
